PTC Therapeutics, Inc. (PTCT)

PTC Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	779.71	594	279.83	189.72	208.81
Short-Term Investments	359.99	282.74	130.87	583.66	894.84
Cash & Short-Term Investments	1,140	876.74	410.71	773.38	1,104
Cash Growth	29.99%	113.47%	-46.89%	-29.93%	60.75%
Receivables	158.55	161.02	155.61	110.46	69.93
Inventory	23.19	30.58	21.81	15.86	18.7
Prepaid Expenses	36.69	147.69	105.66	54.68	39.47
Other Current Assets	7.4	2.6	-	-	-
Total Current Assets	1,366	1,219	693.79	954.37	1,232
Property, Plant & Equipment	117.66	178.99	175.02	130.01	118.24
Long-Term Investments	-	-	-	21	29.3
Goodwill	82.34	82.34	82.34	82.34	82.34
Other Intangible Assets	118.79	379.5	705.89	724.84	715.33
Other Long-Term Assets	20.7	36.25	48.58	25.5	31.32
Total Assets	1,705	1,896	1,706	1,938	2,208
Accounts Payable	17.27	6.05	27.27	23.03	18.67
Accrued Expenses	250.69	372.76	276.33	251.83	209.83
Current Portion of Long-Term Debt	257.82	194.31	72.15	208.83	21.02
Current Portion of Leases	13.36	16	12.37	10.27	8.74
Current Income Taxes Payable	4.7	-	4.71	1.29	4.32
Current Unearned Revenue	5.51	0.8	1.35	-	4.15
Other Current Liabilities	31.62	13.17	12.05	14.1	10.61
Total Current Liabilities	580.98	603.1	406.24	509.35	277.33
Long-Term Debt	2,109	1,904	1,257	956.59	967.88
Long-Term Leases	90.52	114.81	119.54	93.67	102.55
Long-Term Deferred Tax Liabilities	-	55.91	102.83	137.11	136.74
Other Long-Term Liabilities	22.23	36.44	166.64	239.9	241.79
Total Liabilities	2,803	2,714	2,053	1,937	1,726
Common Stock	0.08	0.08	0.07	0.07	0.07
Additional Paid-In Capital	2,575	2,466	2,305	2,124	2,172
Retained Earnings	-3,647	-3,284	-2,657	-2,098	-1,629
Comprehensive Income & Other	-25.89	-1.29	4.8	-24.28	-60.96
Shareholders' Equity	-1,098	-818.56	-347.09	1.44	481.98
Total Liabilities & Equity	1,705	1,896	1,706	1,938	2,208
Total Debt	2,471	2,229	1,462	1,269	1,100
Net Cash (Debt)	-1,331	-1,352	-1,051	-495.99	3.45
Net Cash Growth	-	-	-	-	-99.04%
Net Cash Per Share	-17.33	-18.07	-14.65	-7.04	0.05
Filing Date Shares Outstanding	78.87	76.61	73.82	71.36	70.32
Total Common Shares Outstanding	77.7	75.71	73.1	70.83	69.72
Working Capital	784.55	615.53	287.55	445.02	954.41
Book Value Per Share	-14.13	-10.81	-4.75	0.02	6.91
Tangible Book Value	-1,299	-1,280	-1,135	-805.74	-315.69
Tangible Book Value Per Share	-16.72	-16.91	-15.53	-11.38	-4.53
Machinery	59.76	84.19	66.64	50.8	38.75
Construction In Progress	3.03	24.01	14.35	9.02	5.08
Leasehold Improvements	31.53	30.17	28.97	19.94	8.07

Source: S&P Capital IQ. Standard template. Financial Sources.